KINVENT BIOMECANIQUE announced that it has raised ?16 million in an equity round of funding led by new investor, NOV Santé Actions Non Cotées, a fund managed by Eurazeo SE on January 18, 2024. The transaction included participation from the founder and other returning minority shareholders. NOV Santé Actions Non Cotées, a fund managed by Eurazeo SE will acquire minority stake in the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.45 EUR | +1.11% |
|
+2.65% | +7.79% |
Jul. 05 | Olyzon.tv announced that it has received ?3 million in funding from Eurazeo SE, Ventech SA, Kima Ventures SAS, Better Angle and other investors | CI |
Jun. 20 | Eurazeo: investment in Materrup | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.79% | 6.15B | |
+1.37% | 123B | |
+6.93% | 100B | |
+18.57% | 71.42B | |
+29.35% | 68.59B | |
+26.24% | 47.74B | |
+17.37% | 44.33B | |
+26.68% | 37.78B | |
+10.26% | 26.35B | |
+1.91% | 23.67B |
- Stock Market
- Equities
- RF Stock
- News Eurazeo SE
- KINVENT BIOMECANIQUE announced that it has received ?16 million in funding from Eurazeo SE and other investors